血管护理团队对比教育对周围动脉疾病患者的随机试验
OPTIMIZE PAD-1试验将166例外周动脉疾病且LDL-C≥70 mg/dL的患者随机分为血管护理团队管理组(临床药师+强化降脂算法一步达标)与常规护理+医生教育组。114例随机患者12个月LDL-C变化分别为-49.1%和-5.4%,组间最小二乘均值差-43.7%(P<0.0001)。血管护理团队组12个月时LDL-C<70 mg/dL和<55 mg/dL的达标率分别高于常规护理组3倍和8倍。
要点
- 血管护理团队管理使12个月LDL-C较基线降低49.1%,常规护理仅降低5.4%。
- 血管护理团队组LDL-C<70 mg/dL达标率是常规护理的3倍以上,<55 mg/dL达标率为8倍。
- 基于算法的跨专业团队可快速降低血管病患者LDL-C并助多数患者达标。
核心结论
- OPTIMIZE PAD-1表明,基于算法的跨专业团队项目可利用现有保险和疗法快速降低血管病患者的LDL-C,优化医疗系统可使多数患者达到LDL-C目标。
研究设计与样本
- OPTIMIZE PAD-1随机试验将外周动脉疾病且LDL-C≥70 mg/dL的患者随机分为血管护理团队管理组(含临床药师和强化降脂算法一步达标)与常规护理+医生教育组,药物通过商业保险获取,主要终点为12个月LDL-C百分比变化。
主要发现
- 166例入组患者中74.2%的LDL-C未达标;114例随机患者平均年龄66岁,女性36.0%,黑人15.8%,基线50.9%使用高强度他汀,7.9%使用依折麦布。
- 血管护理团队组12个月LDL-C平均变化为-49.1%(95%CI:-58.7%至-39.5%),常规护理组为-5.4%(95%CI:-15.3%至4.6%),组间最小二乘均值差为-43.7%(95%CI:-57.6%至-29.9%;P<0.0001)。
- 血管护理团队组平均LDL-C从基线100.6 mg/dL降至第4周54.8 mg/dL和12个月50.1 mg/dL。
- 12个月时血管护理团队组达到LDL-C<70 mg/dL的可能性是常规护理组的3倍以上,达到LDL-C<55 mg/dL的可能性是8倍(P<0.0001)。
临床怎么用
- 对于外周动脉疾病且LDL-C≥70 mg/dL的患者,可考虑采用包含临床药师的跨专业血管护理团队和强化降脂算法来快速降低LDL-C并提高达标率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Underutilization of therapies to reduce ischemic risk in peripheral artery disease (PAD) persists. OBJECTIVES: The purpose was to conduct an implementation trial of lipid management in vascular disease. METHODS: The OPTIMIZE PAD-1 (Implementation of Vascular Care Team to Improve Medical Management of PAD Patients) trial randomized patients with peripheral artery disease with low-density lipoprotein cholesterol (LDL-C) ≥70 mg/dL to management via a vascular care team including a clinical pharmacist and an algorithm of intensive lipid management to achieve goal LDL-C in 1 step vs usual care plus provider education. Medications were obtained using commercial insurance. The primary endpoint was percent change in LDL-C at 12 months. RESULTS: Of 166 enrolled patients, 74.2% did not have an LDL-C level at goal. Among 114 randomized patients (mean age 66 years, 36.0% women, and 15.8% Black), 50.9% received high-intensity statin, and 7.9% received ezetimibe at baseline. The mean 12-month LDL-C change was -49.1% (95% CI: -58.7% to -39.5%) with vascular care team management and -5.4% (95% CI: -15.3% to 4.6%) with usual care; the between-group least-squares mean difference was -43.7% (95% CI: -57.6% to -29.9%; P < 0.0001). Mean LDL-C was reduced in vascular care team patients from 100.6 mg/dL at baseline to 54.8 and 50.1 mg/dL by week 4 and month 12, respectively. At 12 months, vascular care team patients were >3 times as likely to achieve LDL-C <70 mg/dL and 8 times as likely to achieve LDL-C <55 mg/dL (P < 0.0001) than usual care. CONCLUSIONS: OPTIMIZE PAD-1 showed that an interprofessional, algorithm-based program can achieve rapid LDL-C lowering in vascular patients using available insurance and therapies, and LDL-C targets can be met in most patients if enabled by optimized systems of care.
引用
- Hess CN, Daffron A, Nehler MR, et al. Randomized Trial of a Vascular Care Team vs Education for Patients With Peripheral Artery Disease. J Am Coll Cardiol. 2024. PMID: 38897676. doi:10.1016/j.jacc.2024.04.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。